vs
BlueLinx Holdings Inc.（BXC）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是BlueLinx Holdings Inc.的1.9倍（$1.4B vs $748.9M），瑞思迈净利率更高（27.6% vs 0.2%，领先27.4%），瑞思迈同比增速更快（11.0% vs 0.2%），过去两年瑞思迈的营收复合增速更高（7.9% vs 2.5%）
BlueLinx Holdings Inc.是美国经营建材与工业产品的批发分销商，总部位于佐治亚州亚特兰大，目前由Shyam Reddy担任公司总裁兼首席执行官，在美国本土相关分销领域开展业务
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
BXC vs RMD — 直观对比
营收规模更大
RMD
是对方的1.9倍
$748.9M
营收增速更快
RMD
高出10.8%
0.2%
净利率更高
RMD
高出27.4%
0.2%
两年增速更快
RMD
近两年复合增速
2.5%
损益表 — Q3 FY2025 vs Q4 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $748.9M | $1.4B |
| 净利润 | $1.7M | $392.6M |
| 毛利率 | 14.4% | 61.8% |
| 营业利润率 | 1.3% | 34.6% |
| 净利率 | 0.2% | 27.6% |
| 营收同比 | 0.2% | 11.0% |
| 净利润同比 | -89.7% | 13.9% |
| 每股收益（稀释后） | $0.20 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BXCRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $748.9M | $1.3B | ||
| Q2 25 | $780.1M | $1.3B | ||
| Q1 25 | $709.2M | $1.3B | ||
| Q4 24 | $710.6M | $1.3B | ||
| Q3 24 | $747.3M | $1.2B | ||
| Q2 24 | $768.4M | $1.2B |
净利润BXCRMD
| Q2 26 | — | $392.6M | ||
| Q4 25 | — | $392.6M | ||
| Q3 25 | $1.7M | $348.5M | ||
| Q2 25 | $4.3M | $379.7M | ||
| Q1 25 | $2.8M | $365.0M | ||
| Q4 24 | — | $344.6M | ||
| Q3 24 | $16.0M | $311.4M | ||
| Q2 24 | $14.3M | $292.2M |
毛利率BXCRMD
| Q2 26 | — | 61.8% | ||
| Q4 25 | — | 61.8% | ||
| Q3 25 | 14.4% | 61.5% | ||
| Q2 25 | 15.3% | 60.8% | ||
| Q1 25 | 15.7% | 59.3% | ||
| Q4 24 | 15.9% | 58.6% | ||
| Q3 24 | 16.8% | 58.6% | ||
| Q2 24 | 15.9% | 58.5% |
营业利润率BXCRMD
| Q2 26 | — | 34.6% | ||
| Q4 25 | — | 34.6% | ||
| Q3 25 | 1.3% | 33.4% | ||
| Q2 25 | 1.9% | 33.7% | ||
| Q1 25 | 1.5% | 33.0% | ||
| Q4 24 | 1.7% | 32.5% | ||
| Q3 24 | 3.2% | 31.6% | ||
| Q2 24 | 3.1% | 31.2% |
净利率BXCRMD
| Q2 26 | — | 27.6% | ||
| Q4 25 | — | 27.6% | ||
| Q3 25 | 0.2% | 26.1% | ||
| Q2 25 | 0.6% | 28.2% | ||
| Q1 25 | 0.4% | 28.3% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | 2.1% | 25.4% | ||
| Q2 24 | 1.9% | 23.9% |
每股收益（稀释后）BXCRMD
| Q2 26 | — | $2.68 | ||
| Q4 25 | — | $2.68 | ||
| Q3 25 | $0.20 | $2.37 | ||
| Q2 25 | $0.54 | $2.58 | ||
| Q1 25 | $0.33 | $2.48 | ||
| Q4 24 | $0.67 | $2.34 | ||
| Q3 24 | $1.87 | $2.11 | ||
| Q2 24 | $1.65 | $1.97 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.4M | $1.4B |
| 总债务越低越好 | $598.5M | $663.8M |
| 股东权益账面价值 | $623.0M | $6.3B |
| 总资产 | $1.6B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.96× | 0.11× |
8季度趋势，按日历期对齐
现金及短期投资BXCRMD
| Q2 26 | — | $1.4B | ||
| Q4 25 | — | $1.4B | ||
| Q3 25 | $429.4M | $1.4B | ||
| Q2 25 | $386.8M | $1.2B | ||
| Q1 25 | $449.0M | $932.7M | ||
| Q4 24 | $505.6M | $521.9M | ||
| Q3 24 | $526.3M | $426.4M | ||
| Q2 24 | $491.4M | $238.4M |
总债务BXCRMD
| Q2 26 | — | $663.8M | ||
| Q4 25 | — | $403.9M | ||
| Q3 25 | $598.5M | $408.7M | ||
| Q2 25 | $596.4M | $658.4M | ||
| Q1 25 | $596.6M | $663.1M | ||
| Q4 24 | $575.1M | $662.9M | ||
| Q3 24 | $576.0M | $667.6M | ||
| Q2 24 | $574.6M | $697.3M |
股东权益BXCRMD
| Q2 26 | — | $6.3B | ||
| Q4 25 | — | $6.3B | ||
| Q3 25 | $623.0M | $6.1B | ||
| Q2 25 | $621.3M | $6.0B | ||
| Q1 25 | $636.1M | $5.5B | ||
| Q4 24 | $646.4M | $5.3B | ||
| Q3 24 | $655.6M | $5.2B | ||
| Q2 24 | $652.3M | $4.9B |
总资产BXCRMD
| Q2 26 | — | $8.5B | ||
| Q4 25 | — | $8.5B | ||
| Q3 25 | $1.6B | $8.3B | ||
| Q2 25 | $1.6B | $8.2B | ||
| Q1 25 | $1.6B | $7.6B | ||
| Q4 24 | $1.6B | $7.1B | ||
| Q3 24 | $1.6B | $7.2B | ||
| Q2 24 | $1.6B | $6.9B |
负债/权益比BXCRMD
| Q2 26 | — | 0.11× | ||
| Q4 25 | — | 0.06× | ||
| Q3 25 | 0.96× | 0.07× | ||
| Q2 25 | 0.96× | 0.11× | ||
| Q1 25 | 0.94× | 0.12× | ||
| Q4 24 | 0.89× | 0.13× | ||
| Q3 24 | 0.88× | 0.13× | ||
| Q2 24 | 0.88× | 0.14× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $58.6M | — |
| 自由现金流经营现金流 - 资本支出 | $52.7M | — |
| 自由现金流率自由现金流/营收 | 7.0% | — |
| 资本支出强度资本支出/营收 | 0.8% | — |
| 现金转化率经营现金流/净利润 | 35.42× | — |
| 过去12个月自由现金流最近4个季度 | $-25.1M | — |
8季度趋势，按日历期对齐
经营现金流BXCRMD
| Q2 26 | — | — | ||
| Q4 25 | — | $339.7M | ||
| Q3 25 | $58.6M | $457.3M | ||
| Q2 25 | $-26.8M | $538.8M | ||
| Q1 25 | $-33.9M | $578.7M | ||
| Q4 24 | $18.7M | $308.6M | ||
| Q3 24 | $61.8M | $325.5M | ||
| Q2 24 | $35.8M | $440.1M |
自由现金流BXCRMD
| Q2 26 | — | — | ||
| Q4 25 | — | $311.2M | ||
| Q3 25 | $52.7M | $414.4M | ||
| Q2 25 | $-36.4M | $508.2M | ||
| Q1 25 | $-39.8M | $557.9M | ||
| Q4 24 | $-1.5M | $288.0M | ||
| Q3 24 | $53.8M | $307.7M | ||
| Q2 24 | $29.3M | $415.2M |
自由现金流率BXCRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 21.9% | ||
| Q3 25 | 7.0% | 31.0% | ||
| Q2 25 | -4.7% | 37.7% | ||
| Q1 25 | -5.6% | 43.2% | ||
| Q4 24 | -0.2% | 22.5% | ||
| Q3 24 | 7.2% | 25.1% | ||
| Q2 24 | 3.8% | 33.9% |
资本支出强度BXCRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 2.0% | ||
| Q3 25 | 0.8% | 3.2% | ||
| Q2 25 | 1.2% | 2.3% | ||
| Q1 25 | 0.8% | 1.6% | ||
| Q4 24 | 2.9% | 1.6% | ||
| Q3 24 | 1.1% | 1.5% | ||
| Q2 24 | 0.8% | 2.0% |
现金转化率BXCRMD
| Q2 26 | — | — | ||
| Q4 25 | — | 0.87× | ||
| Q3 25 | 35.42× | 1.31× | ||
| Q2 25 | -6.21× | 1.42× | ||
| Q1 25 | -12.09× | 1.59× | ||
| Q4 24 | — | 0.90× | ||
| Q3 24 | 3.86× | 1.05× | ||
| Q2 24 | 2.50× | 1.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BXC
| Specialty Products | $525.5M | 70% |
| Structural Products | $223.4M | 30% |
RMD
暂无分部数据
